Tiziana Life Sciences
TLSA
5 hedge funds and large institutions have $4.18M invested in Tiziana Life Sciences in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
0.07% more ownership
Funds ownership: 2.2% → 2.27% (+0.07%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
10% less capital invested
Capital invested by funds: $4.64M → $4.18M (-$461K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HAG
HighPoint Advisor Group
Downers Grove,
Illinois
|
+$85.7K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$46.3K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.88K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
-$9.31K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
TLSA Hedge Fund Activity: Q3 2019 in Review
5 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q3 2019, worth a combined $4.18M — down 9.9% from $4.64M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TLSA positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was HighPoint Advisor Group, adding an estimated $85.7K. The largest seller was HighTower Advisors, cutting an estimated $9.31K.
- 5 institutional investors held Tiziana Life Sciences (TLSA) as of Q3 2019, up from 4 in Q2 2019.
- Funds reported $4.18M of Tiziana Life Sciences stock for Q3 2019, down 9.9% quarter-over-quarter.
- 2 funds opened new Tiziana Life Sciences positions in Q3 2019 and 1 closed out, a net change of +1 holder.
- The largest Tiziana Life Sciences buyer in Q3 2019 was HighPoint Advisor Group, an estimated $85.7K added.
- The largest Tiziana Life Sciences seller in Q3 2019 was HighTower Advisors, an estimated $9.31K sold.
Based on aggregated 13F filings for Q3 2019.